Lack of expertise and funding are hampering prostate cancer screening and treatmentBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7376.1322/e (Published 07 December 2002) Cite this as: BMJ 2002;325:1322
- Caroline White
A lack of widespread expertise and adequate funding–rather than the screening test itself–is hampering screening for and treatment of prostate cancer, claims a leading cancer epidemiologist.
Professor Peter Boyle, of the European Institute of Oncology, was speaking in advance of a conference on the opportunities and challenges faced by screening programmes in London last week. One in 14 men will develop prostate cancer, the second most common cancer in men in the United Kingdom, and 9500 men die from the disease every year. Four out of five cases diagnosed are in men over the age of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial